Maraninchi D - Search Results

1

In vitro inhibition of interleukin-2-induced defective polymorphonuclear chemotaxis by TNF inhibitor.

Fossat C, Sainty D, Stoppa AM, Blaise D, David M, Maraninchi D, Juhan-Vague I. Fossat C, et al. Among authors: maraninchi d. Eur J Haematol. 1993 Jul;51(1):13-7. doi: 10.1111/j.1600-0609.1993.tb00598.x. Eur J Haematol. 1993. PMID: 8348939

2

Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment.

Fossat C, Sainty D, Stoppa AM, Maraninchi D, Juhan-Vague I. Fossat C, et al. Among authors: maraninchi d. Nouv Rev Fr Hematol (1978). 1992;34 Suppl:S61-4. Nouv Rev Fr Hematol (1978). 1992. PMID: 1340531

3

Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies.

Vialettes B, Guillerand MA, Viens P, Stoppa AM, Baume D, Sauvan R, Pasquier J, San Marco M, Olive D, Maraninchi D. Vialettes B, et al. Among authors: maraninchi d. Acta Endocrinol (Copenh). 1993 Jul;129(1):31-8. doi: 10.1530/acta.0.1290031. Acta Endocrinol (Copenh). 1993. PMID: 8351956

4

Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration.

Stoppa AM, Vey N, Sainty D, Arnoulet C, Camerlo J, Cappiello MA, Gastaut JA, Maraninchi D. Stoppa AM, et al. Among authors: maraninchi d. Br J Haematol. 1996 Apr;93(1):42-4. doi: 10.1046/j.1365-2141.1996.453993.x. Br J Haematol. 1996. PMID: 8611473

5

Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.

Vey N, Viens P, Fossat C, Olive D, Sainty D, Baume D, Stoppa AM, Bouabdallah R, Brandely M, Gastaut JA, Maraninchi D, Blaise D. Vey N, et al. Among authors: maraninchi d. Eur Cytokine Netw. 1997 Dec;8(4):389-94. Eur Cytokine Netw. 1997. PMID: 9459619 Free article.

6

Interleukin 2 in the treatment of acute leukemia.

Blaise D, Maraninchi D. Blaise D, et al. Among authors: maraninchi d. Leuk Res. 1998 Dec;22(12):1165-70. doi: 10.1016/s0145-2126(98)00115-5. Leuk Res. 1998. PMID: 9922080 Review. No abstract available.

7

Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.

Vey N, Blaise D, Lafage M, Olive D, Viens P, Baume D, Camerlo J, Stoppa AM, Gabus R, Brandely M, Hercend T, Maraninchi D. Vey N, et al. Among authors: maraninchi d. J Immunother. 1999 Mar;22(2):175-81. doi: 10.1097/00002371-199903000-00009. J Immunother. 1999. PMID: 10093042 Clinical Trial.

8

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse.

Maraninchi D, Blaise D, Viens P, Brandely M, Olive D, Lopez M, Sainty D, Marit G, Stoppa AM, Reiffers J, et al. Maraninchi D, et al. Blood. 1991 Nov 1;78(9):2182-7. Blood. 1991. PMID: 1932739 Free article.

9

High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients.

Lejeune C, Tubiana N, Gastaut JA, Maraninchi D, Richard B, Launay MC, Sainty D, Sebahoun G, Carcassonne Y. Lejeune C, et al. Among authors: maraninchi d. Eur J Haematol. 1990 Apr;44(4):240-3. doi: 10.1111/j.1600-0609.1990.tb00386.x. Eur J Haematol. 1990. PMID: 2344886

10

Liquid culture and cryopreservation of marrow cells of leukaemic patients prior to autologous bone marrow transplantation.

Stoppa AM, Maraninchi D, Lafage M, Mannoni P, Novakovitch G, Blaise D, Gaspard MH, Michel G, Carcassonne Y. Stoppa AM, et al. Among authors: maraninchi d. Br J Haematol. 1989 Aug;72(4):519-23. doi: 10.1111/j.1365-2141.1989.tb04316.x. Br J Haematol. 1989. PMID: 2673330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters